Unyango olusakhuthaza abantwana kunye nabaselula
I-Intuniv yinkqubo engeyiyo inomdla yokunakekelwa kwengxaki yokuxhatshazwa kwengxaki ( ADHD ). Kuhlobo olude lwe-guanfacine, eyayisetyenziswe ngaphambili ukuphatha uxinzelelo lwegazi oluphezulu. Yavunywe yi-FDA ngoSeptemba 2009. Ekuqaleni yavunywa njengonyango lwamaxesha kubantwana nabaselula abaneminyaka engama-6 ukuya kwe-17 ubudala kunye ne-ADHD.
Ngo-2011, i-Intuniv ithole isibonakaliso esitsha sokusetyenziswa njengonyango oluchaziweyo kwi-ADHD, oku kuthetha ukuba isenokusetyenziswa kunye ne-ADHD ekhuthazayo, njenge-Concerta, Focalin, Adderall XR, okanye i-Vyvanse, njl.
Intuniv kwi-ADHD
Ezinye izinto ezaziyo malunga ne-Intuniv ziquka ukuba:
- UGufacfacine wayesele esebenzisa i-ileyibhile ukuze aphathe abantwana abane-ADHD nabo banama-tics, iingxaki zokulala, okanye ugonyamelo.
- I-Intuniv yipilisi, kodwa ngokungafani namanye amachiza e-ADHD, ayikwazi ukuchotshozwa, ukuhlaselwa, okanye ukuphulwa kwaye kufuneka igonywe ngokupheleleyo.
- NjengoStrattera kunye neKapvay, ezinye izinto ezingenakuvuselela i-ADHD, i-Intuniv ayikho into elawulwayo, enokukwenza ukuba i-refills ibe lula kubazali.
- I-Intuniv ifumaneka kumandla amane omlinganiselo: i-milligram, i-milligram, ii-milligram, ii-milligrams ezi-4.
- Uninzi lwabantwana luya kuqala i-Intuniv kwi-1-milligram isilinganiselo kwaye yanda nge-milligram eyi-1 nganye iveki ide ifike kwiqondo elijoliswe kwi-milligrams okanye ii-milligram ezi-4. Gcina ukhumbule ukuba ekubeni unokwandisa umthamo, kuthatha iiveki ezintathu okanye ezine ukuba ubone ukuphucula iimpawu ze-ADHD zomntwana xa eqala ukuthatha i-Intuniv.
- Ngo-2013, i-FDA ivumele ukuxhaswa kwesisindo, isisombululo se-pediatric pediatric, esinezixa eziphezulu ukuya kuma-7-milligrams kubantwana abadala. Isisombululo esisekelwe kwisisindo esisisiseko sisuka kwi-0.05 ukuya kwi-0.12 milligram / kilogram / ngosuku.
Ngokuqhelekileyo inzuzo ye-Intuniv, ngokungafani namanye amayeza e-ADHD , ngokukodwa okukhuthaza njenge-Adderall, i-Concerta, okanye i- Vyvanse , ukuba ayibangele ukunyanzelisa ukutya.
Oko kungenza kube yinto enhle kubantwana abanenkathazo yokunyuka xa bethatha ukuvuselela.
Izixwayiso ze-Intuniv kunye neempembelelo ezingasemva
Iziphumo eziphambili ze-Intuniv zivame ukuquka ukungabikho komzimba (ezinokuthi zenzeke kwiipesenti ezingama-38 zezigulane), iintloko, ukukhathala, ubuhlungu besisu esiswini, isisulu, isisulu, ukuxakeka, ukuxutha, ukunciphisa uxinzelelo lwegazi kunye nokunciphisa ukutya.
Nangona ukungazinzi kubakho kwinani elikhulu labantwana xa beqala ukuthatha i-Intuniv, kubonakala ukuba ngcono xa beqhubeka beyithatha. Kwabanye abantwana, le nto inzuzo, njengoko ibancedisa ukuba balele xa benikwa umthamo ngexesha lokulala (Intuniv inokunikwa ekuseni okanye ngokuhlwa).
Izilumkiso malunga ne-Intuniv ziquka:
- Intuniv kufuneka isetyenziswe xa umntwana wakho esemngciphekweni wegazi ophantsi, i-bradycardia (izinga eliphantsi lentliziyo), i-heart block, okanye i-syncope (ukuphelelwa amandla), kunye nabo bathatha i-ketoconazole, i-rifampin, i-valproic acid, iziyobisi ezingathinteliyo, okanye i-CNS. ama-sedative, antipsychotics, njl.).
- I-Intuniv ayifanele ithathwe ngesidlo esinamafutha aphezulu. Ingathathwa ngamanzi, ubisi, okanye ezinye izixhobo zamanzi.
- I-Intuniv ifanele ishiywe ngokukhawuleza, ngokunciphisa okanye ukupakisha idosi kwiiveki ezimbalwa, kwaye akufanele imeke ngokukhawuleza.
I-Pediatric Focused Review of Review yi-FDA ngonyaka ka-2013 uncetyiswa ukuhlolwa kwe-Intuniv. Ikomidi elijongene neNtliziyo lijonganisa le mveliso ngo-2018.
Ngaba Umntwana Wakho Nge-ADHD uzama Intuniv?
I-Intuniv inokuba yinto ekhethekileyo kakhulu ukuba imithi yengane yakho yangoku ingasebenzi kakuhle, ayikwazi ukunyamezela ezinye izikhuthazo ngenxa yemiphumo emibi , okanye ukuba uye wakhathazeka ngokubeka umntwana wakho kuvuselelo.
NjengoTenex, sinokubona i-intuniv isetyenziselwa ukuphatha abantwana abane-ADHD kunye ne-tics, iingxaki zokulala, okanye ukugonywa, nokuba ngokwazo okanye ngokuvuselela.
> Imithombo:
> Childress AC. I-Guanfacine Yandisa Ukukhutshwa Njengengonyango Ejongene Neengxaki Zengqondo Kwabantwana Nengane Ejongene Neengxaki Ukunyamekela-Ukulahleka / Ukuxhalabisa. Uphuhliso lwezonyango . 2012; 29 (5): 385-400. i-doi: 10.1007 / s12325-012-0020-1.
> Elbe D, Reddy D. Gxila kwi-Guanfacine Ukukhululwa okongeziweyo: Ukuphononongwa kokusetyenziswa kwayo kwi-Psychiatry yabantwana kunye nabantwana abaselula. Umbhalo we-Canadian Academy of Child and Adolescent Psychiatry . 2014; 23 (1): 48-60.
> Huss M, Dirks B, Gu J, Robertson B, Newcorn JH, uRamos-Quiroga JA. Ukukhuseleka kwexesha elide kunye nokusebenza kwe-Guanfacine Ukukhululwa Kwabantwana nakwi-Adolescents With ADHD. Umntwana waseYurophu kunye neNtsholongwane yengqondo ye-Psychiatry . 2018. Ithenda: 10.1007 / s00787-018-1113-4.
> I- Intuniv yokuBhala ngokupheleleyo i-Information Sheets . Shire US Inc. https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/022037s009lbl.pdf.
> I-Pediatric Focus Focused Review FDA. Umhlangano weeKomiti zoMcebisi ngezeNtloko ngoSeptemba 2013.